Gene Therapy Genetic Engineering And Cell Potency

Stem cells can be derived from various sources, including not just mammals, but also other vertebrates like birds and fish, as well as some invertebrates. Stem cells provide a powerful tool for drug screening and toxicology studies. They can be used to generate specific types of cells that are targeted by drugs, allowing researchers to evaluate the efficacy and safety of new pharmaceutical compounds before proceeding to clinical trials. Stem cells have the potential to be used in regenerative medicine to repair or replace damaged tissues and organs. This includes a wide range of applications, from bone marrow transplants (a well-established stem cell therapy for certain blood disorders) to experimental treatments for neurodegenerative diseases, heart disease, diabetes, and more.

**Statement 1 is correct:** Recombinant DNA technology allows genes to be transferred between different plant species to develop desired traits. **Statement 2 is correct:** Genes from animals can be inserted into plants (e.g., Bt toxin genes from bacteria into plants, or other examples in research), so cross-kingdom gene transfer is possible. **Statement 3 is correct:** Microbial genes are routinely transferred to higher organisms, such as insulin gene from bacteria to humans for production. Therefore, all three statements are correct.

Somatic Cell Nuclear Transfer (SCNT) technology is primarily used for the purpose of reproductive cloning of animals.  SCNT can be used to create genetically identical copies of animals. This involves transferring the nucleus of a somatic (body) cell into an egg cell that has had its own nucleus removed. The egg cell is then stimulated to divide and develop into an embryo, which is then implanted into a surrogate mother to produce a cloned individual. This technique is called reproductive cloning.

* Cas9 protein is a revolutionary tool in the field of genetic engineering.  * Cas9 is an RNA-guided endonuclease, an enzyme. It acts like molecular scissors, capable of cutting DNA at specific locations within a cell's genome. * Cas9 plays a crucial role in the CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) technique, a powerful gene editing tool.

**Option A is incorrect.** While it is possible to create artificial DNA sequences in a laboratory, creating a fully functional chromosome by joining DNA segments from different species is not currently feasible. Chromosomes are complex structures, and recreating a functional chromosome from scratch is an extremely challenging task. Thus, **Option B is correct.** Advances in synthetic biology and genetic engineering have made it possible to create artificial DNA sequences with desired functions in a laboratory setting. **Option C is correct.** Techniques like in vitro DNA replication and polymerase chain reaction (PCR) allow for the replication of DNA fragments outside of a living cell, in a controlled laboratory environment. **Option D is correct.** Techniques like cell culture and tissue culture allow for the growth and division of cells taken from plants and animals in a controlled laboratory environment.

**Statement 1 is correct.** Techniques like CRISPR-Cas9 allow the editing of genes in sperm or egg cells (germline cells) before fertilization. This can potentially correct genetic diseases passed on to future generations. **Statement 2 is correct.** Genome editing in early embryos CRISPR and other techniques can be used to edit genes in embryos at a very early stage of development. This allows for correcting genetic defects before implantation in the womb, potentially preventing the child from inheriting the disease. **Statement 3 is correct.** Scientists can reprogram adult human cells into induced pluripotent stem cells (hiPSCs) that have the potential to develop into any cell type. These hiPSCs can be injected into animal embryos, like pigs, to create chimeric embryos containing both human and animal cells. This technology is used for research purposes to study human development and disease. All three statements are correct.

**Statement 1 is correct.** Genetic engineering in vaccine development works by modifying the genetic material of viruses, bacteria, or lab-grown cells to produce specific proteins that trigger an immune response. Scientists first identify a target protein from a pathogen that can help the immune system recognize and fight it. They then insert the gene coding for this protein into a harmless virus, bacterial cell, or a lab-grown system, which acts as a factory to produce large amounts of the antigen. The antigen is then purified and combined with other ingredients to create the final vaccine. When injected, the vaccine stimulates the immune system to recognize and attack the actual pathogen if encountered in the future. This approach is used in various vaccines, including mRNA vaccines like those for COVID-19 and recombinant protein vaccines like the Hepatitis B vaccine.  **Statement 2 is correct.** Bacteria and viruses are commonly used as vectors in recombinant vector vaccines. These vectors serve as delivery vehicles to transport genetic material from the target pathogen into host cells, where the antigens are produced. The host immune system then recognizes these antigens and mounts an immune response. | Vector Type | Examples of Vectors | |------------------|--------------------------------------------------------------------------------------------------------| | Viral Vectors | Adenovirus, Vaccinia Virus (MVA), Vesicular Stomatitis Virus (VSV), Measles Virus, Influenza Virus | | Bacterial Vectors| Salmonella typhimurium, Listeria monocytogenes, Mycobacterium bovis (BCG) | | Fungal Vectors | Saccharomyces cerevisiae (Yeast) | | Protozoan Vectors| Leishmania donovani, Trypanosoma cruzi |